Navigation Links
35th ESMO Congress: Milan, Italy (FieraMilanoCity), 8-12 October 2010 - Press Programme Curtain Raiser
Date:10/4/2010

disease control in some patients in a Phase-II clinical trial.

G. Long, AU

Melanoma drug shrinks brain metastases in Phase-I/II study (embargo: 10 October, 11:00 Milan time)

A new drug being developed to treat potentially deadly melanoma skin cancers has shown a promising ability to shrink secondary tumors, known as metastases, in the brain in patients with advanced forms of the disease.

A. Palumbo, IT

High response rate seen in Phase-III trial of chemotherapy, new drug and stem cells in myeloma (embargo: 10 October, 12:30 Milan time)

The first study of its kind comparing two different approaches to treating newly diagnosed multiple myeloma has found that both treatments achieved a positive response.

M. Clavarezza, IT

Most Italian breast cancer patients older, and diagnosed very early (embargo: 10 October, 12:30 Milan time)

A study of breast cancer in Italian women has found that more than 70% of those affected by the disease are over the age of 50 years, and the disease is identified before it has spread to the lymph nodes in more than 60% of cases.

H.A. Azim, BE

Study finds breast-feeding safe for women after breast cancer treatment (embargo: 10 October, 12:30 Milan time)

Women who have survived breast cancer should not be denied the opportunity to breast-feed their children. There is no evidence that breastfeeding is dangerous for mother or child after breast cancer treatment.

K.M. Tveit, NO

Cetuximab adds no benefit to chemotherapy in first-line treatment of metastatic colorectal cancer - New Phase-III data (embargo: 10 October, 13:30 Milan time)

Adding the targeted drug cetuximab to a three-drug chemotherapy regimen for first-line treatment of metastatic colorectal cancer does not improve response rate, progression-free survival or overall survival.

A. Gennari, IT

Prolonging first-line chemotherapy improves outcomes for patien
'/>"/>

SOURCE European Society for Medical Oncology (ESMO)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Wound Management Technologies (OTCBB- WNDM) Signs Biotech Agreement With Biocure S.r.l. of Milan, Italy
2. European Masters of Poker Italy Online Qualification in Full Swing
3. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
4. CVS Caremark Recognizes Its 26,000 Pharmacists During Octobers American Pharmacists Month
5. American College of Surgeons Clinical Congress Convenes in Washington, DC, October 3-7, 2010
6. Cobalis Corp. Announces Second Update Conference Call for Investors on October 5, 2010
7. Stryker to Host Conference Call on October 19, 2010
8. Alexza Announces AZ-004 (Staccato(R) Loxapine) PDUFA Goal Date of October 11, 2010
9. Solos Endoscopy, Inc. Reports Sales Increase for October 2009 and November 2009 as Compared to Same Two Months in 2008
10. Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase
11. Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014  Iliad Neurosciences, Inc., a ... diagnosing and treating Autism Spectrum Disorders (ASD) announced today ... with The Research Foundation for The State University of ... provide a new biomarker to identify an abnormality in ... ASD. This biomarker is expected to be available for ...
(Date:9/18/2014)... , Sept. 18, 2014  ePharmaSolutions, ... was recognized as the Disruptive Innovator of ... ePharmaONE cloud-based eClinical platform. This solution includes ... trial master file (eTMF), a remote monitoring ... ePharmaSolutions, ReferralPlus+ patient screening and matching technology. ...
(Date:9/18/2014)... PLAINSBORO, N.J. , Sept. 18, ... of the National Hemophilia Foundation,s (NHF) new three-year ... support to people with hemophilia and their families/caregivers ... that can impede disease management. The curriculum for ... With Your Provider About Pain , focuses on ...
Breaking Medicine Technology:Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 2Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 3ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform 2ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform 3Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program 2Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program 3
... 1 RX-3341 Results -, NEW HAVEN, Conn., ... "Company"), a development-stage company focused on the,discovery and ... infections, today announced the initiation of a Phase,2 ... compound RX-3341 in,the treatment of complicated skin and ...
... Will Remain as the Clinical Gold Standard ... New Report from Decision Resources, WALTHAM, Mass., ... leading research and advisory firms focusing on pharmaceutical ... in preventing,recurrence of depressive mood episodes in patients ...
Cached Medicine Technology:Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 2Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 3Current and Emerging Drugs Continue to Struggle for Patient Share in the Treatment of Major Depressive Disorder 2
(Date:9/19/2014)... September 19, 2014 VogueQueen.com ... dresses that will make ladies more beautiful at their ... that everyone can afford. The company’s new products are ... providing offering great savings for all the global clients. ... are extremely beautiful. I have ordered several items on ...
(Date:9/18/2014)... 2014 Defendants in more than ... pending in Pennsylvania’s Philadelphia Court of Common Pleas ... behalf of out-of-state plaintiffs dismissed, Bernstein Liebhard LLP ... the defendants maintain that circumstances surrounding the alleged ... have no connection to Pennsylvania. The filings did ...
(Date:9/18/2014)... ON (PRWEB) September 18, 2014 Dr. ... Plastic Surgeon with the American Academy of Facial Plastic ... of Toronto in the Division of Facial Plastic Surgery. ... work in facial plastic surgery. , Dr. Ellis ... foremost, he will be presenting on injection techniques and ...
(Date:9/18/2014)... Exposure to diverse communities may boost infants, social learning, ... languages in the park or supermarket could help children ... are different from them, researchers found. "Research ... against interacting with and learning from people who are ... Chicago psychology professor, said in a university news release. ...
(Date:9/18/2014)... 18, 2014 "Medical staff need better ... also maintaining the patient's privacy," said one of two ... idea in order to supply caregivers with the equipment ... created a prototype for The Helper to make it ... to turn patient onto his or her side. It ...
Breaking Medicine News(10 mins):Health News:VogueQueen.com’s New Line Of Cheap Wedding Dresses Aims To Attract Chic Ladies 2Health News:Xarelto Lawsuit Defendants Seek to Have Pennsylvania Claims Filed by Out-of-State Plaintiffs Dismissed, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Defendants Seek to Have Pennsylvania Claims Filed by Out-of-State Plaintiffs Dismissed, Bernstein Liebhard LLP Reports 3Health News:Dr. David A. F. Ellis Has Been Invited to Speak at a Conference of the American Academy of Facial Plastic and Reconstructive Surgery in Orlando, Florida 2Health News:Study: Exposure to Diversity Might Boost Baby's Social Skills 2
... TSX: COM , VANCOUVER, Nov. 6 /PRNewswire-FirstCall/ - Cardiome ... announced that it will report financial results for the third ... November 9, 2009. Cardiome will hold a teleconference call and ... discuss the results. , To access the conference call, please ...
... The Leukemia & Lymphoma Society (LLS) will again be participating ... two campaigns this past spring and summer, garnered more than $1 ... and support services. , During the campaign, taking place from November ... discount coupons participants can use (in-store only) at all ...
... , WASHINGTON, Nov. 6 The U.S. bishops sent an ... as House members steeped themselves in debate over procedures related ... before meeting to discuss proposed amendments to the bill, the ... of "an amendment to keep in place current federal law ...
... VA)--Three leading scientific organizations specializing in infectious diseases ... expressing their significant concern with current federal guidance ... by healthcare workers in treating suspected or confirmed ... Society for Healthcare Epidemiology of America (SHEA), the ...
... researcher says , FRIDAY, Nov. 6 (HealthDay News) -- New ... within five years of developing the disease are more likely ... others with the condition. , The findings, published Nov. 4 ... who relapse within five years of developing it are nearly ...
... ... Product Lines , ... (PRWEB) November 6, 2009 -- WAV, Inc., the value-added distributor of ... with Vecima Networks Inc. (TSX:VCM), a leading provider of equipment supporting broadband access ...
Cached Medicine News:Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3Health News:Get a Jump on Your Holiday Shopping and Give Two Gifts This Season: One to Your Loved Ones and One to People Battling Blood Cancer 2Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 2Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 3Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 4Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 5Health News:Prevention experts urge modification to 2009 H1N1 guidance for health care workers 2Health News:Early Relapse of MS May Mean Fewer Issues Later 2Health News:WAV Distribution Partners with Vecima Networks Inc. 2Health News:WAV Distribution Partners with Vecima Networks Inc. 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: